Comparison

N15 Beta-Amyloid (11-40), Uniformly Labeled

Item no. RPE-A-1137-1
Manufacturer rPeptide
Amount 1 mg
Category
Type Peptides
Format Lyophilized powder
Specific against other
Purity >97%
Sequence E V H H Q K L V F F A E D V G S N K G A I I G L M V G G V V
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Available
Territory
This product is only available for customers from Austria or Switzerland!
Manufacturers Category
Human, Native, Mutant, Beta-Amyloid Peptides, Recombinant, E. Coli
Storage
-20°C
Shipping
Ambient
Description (Long)
Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be the cause of Alzheimer’s Disease (AD). Alzheimer’s diseased brains show significant levels of Abeta (11-40) and Abeta (11-42). The ß-secretase enzyme or ß- amyloid precursor protein-cleaving enzyme (BACE) generates the N terminus of Aß, producing full-length Abeta (1-40 and 1-42) and/or truncated Abeta (11-40 and 11-42). The abundance of Abeta (11-40 and 11-42) produced by BACE suggests that they might be playing an important role in Alzheimer’s disease pathogenesis.
Physical State
White lyophilized powder

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close